Condition: Non-hodgkin Lymphoma,B Cell · Multiple Myeloma · Acute Lymphoblastic Leukemia, Adult · Sponsor: Northside Hospital, Inc.
This is a prospective, descriptive study designed to assess the feasibility of administering CAR T therapy among patients with moderate to severe renal impairment using dose adjusted lymphodepleting chemotherapy.
This description comes directly from the study's public registry record.
Melhem Solh, MD · 404-255-1930 · msolh@bmtga.com
Caitlin Guzowski, MBA, MHA · 404-851-8523 · caitlin.guzowski@northside.com
Always discuss trial participation with your own doctor first.
| Caitlin Guzowski | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05909059